Savvy Updates, 12/5/22: Ypsomed MyLife Loop, Insulin Resistance & CVD & Depression, HearO App Predicts Heart Failure, Biscuits, Low Carb Grilled Feta, Cows Wearing Trackers

Ypsomed, CamDiab launch first automated insulin dosing system with Abbott FreeStyle Libre 3 was reported by Sean Whooley for, 28 November 2022. Ypsomed announced that its mylife Loop now has authorization to work with the Abbott FreeStyle Libre 3 sensor in Germany. Abbott, Ypsomed, and CamDiab announced a partnership to develop an AID earlier this year. … Read more

Savvy Updates, 11/28/22: Wearable/Stretchable Tracking Devices, iTolerance Tech Without Immunosuppression, PBM Reform HIGH Priority, Allulose, W!LD Winter 2022

How wearable devices with skin-like stretchability may pave way for better health tracking was reported by Nick Paul Taylor for, 21 November 2022. The DOE’s Argonne National Laboratory teamed up with the University of Chicago’s Pritzker School of Molecular Engineering to tackle two challenges associated with the development of stretchable devices for tracking health … Read more

Savvy Updates, 11/21/22: Insulet Omnipod 5 Controller Recall, Provention Bio’s Teplizumab (Tzield), Rezvoglar Biosimilar, Sugar Alcohols, Stevia, Veggies & Rock Music

Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod 5 Controller  Insulet Corporation announced a Medical Device Correction for the Omnipod 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging port and cable. This does not impact the Omnipod 5 Pod, the Omnipod DASH Insulin Management System, … Read more

Savvy Updates, 11/14/22: World Diabetes Day, Lilly’s Tempo D Management, Chemical “Tag” for Insulin, Dietary Fat, Vegan & T1D

World Diabetes Day is every year on November 14, first created in 1991 by the International Diabetes Foundation and the World Health Organization.  The day 14 November was chosen to commemorate the birthday of Sir Frederick Banting, co-discoverer of Insulin along with Charles Best in 1922.  The blue circle is the global symbol for diabetes awareness and the logo … Read more

Savvy Updates 11/7/22: Insulet Hits Record # of New Customers, What To Do If You Take Too Much Insulin, Air Bubbles in Pumps

Insulet reports record number of new customers on Omnipod 5 launch; shares climb was reported by Elise Reuter for, 4 November 2022. Insulet, the maker of the Omnipod 5 insulin pump, recorded a record number of new customers in the third quarter, spurring the company to boost its full-year revenue forecast. The shares surged.  The … Read more

Savvy Updates, 10/31/22: Dexcom Profit Surges, New Islet Cell Transplant Method, Almonds and Gut Microbiome, Breath Vapors Algorithm into BG Readings

Dexcom Q3 profit surges as CGM maker prepares for G7 launch in U.S. was reported by Elise Reuter for, 28 October 2022. The company expects to begin selling its newest continuous glucose monitor in the first quarter of 2023 if it receives FDA approval this year. Dexcom reported another quarter of double-digit revenue growth, driven by … Read more

Savvy Updates, 10/24/22: Omnipod DASH PDM Recall, Insulin Rationing in the US (SHAMEFUL!), Wearable Tech to Charge Devices

Insulet flags battery problem with Omnipod DASH system was posted by Elise Reuter for, 17 October 2022.   Insulet issued an urgent medical device correction, on 17 October 2022, related to battery problems with a component of its Omnipod DASH system. The device uses a wearable insulin pod that’s controlled by a personal diabetes manager (PDM), a … Read more

Savvy Updates, 10/17/22: Dexcom G7 Global Rollout, T2D Drugs Help T1Ds, BefA Gut Bacteria & Beta Cell Production, FDA TAP Pilot Program for New D Devices

Dexcom Announces Global Rollout of G7, as reported by Andrew Briskin for, 10 October 2022. Dexcom, one of the leading manufacturers of CGM, announced on Oct. 4 that its latest product, the Dexcom G7, is now available for people with diabetes, ages 2 and up, in five additional countries: United Kingdom, Ireland, Germany, Austria, and Hong … Read more

Savvy Updates, 10/10/22: Indigo Continuous Multi-Metabolite (CMM) Sensor, T1D More Difficult/Dangerous for Girls

Indigo Diabetes enrolls first subject in multi-metabolite sensor trial was published by, 30 September 2022.   Belgian diabetes device company Indigo Diabetes has enrolled the first participant in the Shine (multi-center, open-label, prospective, interventional feasibility study that aims to assess the safety of implantation and preliminary performance of the CMM sensor) clinical trial. The trial’s … Read more